These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36030249)

  • 1. The neurophysiological effect of NMDA-R antagonism of frontotemporal lobar degeneration is conditional on individual GABA concentration.
    Perry A; Hughes LE; Adams N; Naessens M; Murley AG; Rouse MA; Street D; Jones PS; Cope TE; Kocagoncu E; Rowe JB
    Transl Psychiatry; 2022 Aug; 12(1):348. PubMed ID: 36030249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABAergic cortical network physiology in frontotemporal lobar degeneration.
    Adams NE; Hughes LE; Rouse MA; Phillips HN; Shaw AD; Murley AG; Cope TE; Bevan-Jones WR; Passamonti L; Street D; Holland N; Nesbitt D; Friston K; Rowe JB
    Brain; 2021 Aug; 144(7):2135-2145. PubMed ID: 33710299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition.
    Murley AG; Rouse MA; Jones PS; Ye R; Hezemans FH; O'Callaghan C; Frangou P; Kourtzi Z; Rua C; Carpenter TA; Rodgers CT; Rowe JB
    Brain; 2020 Dec; 143(11):3449-3462. PubMed ID: 33141154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apathy and impulsivity in frontotemporal lobar degeneration syndromes.
    Lansdall CJ; Coyle-Gilchrist ITS; Jones PS; Vázquez Rodríguez P; Wilcox A; Wehmann E; Dick KM; Robbins TW; Rowe JB
    Brain; 2017 Jun; 140(6):1792-1807. PubMed ID: 28486594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontotemporal lobar degeneration changes neuronal beta-frequency dynamics during the mismatch negativity response.
    Perry A; Hughes LE; Adams NE; Naessens M; Kloosterman NA; Rouse MA; Murley AG; Street D; Jones PS; Rowe JB
    Neuroimage Clin; 2024; 44():103671. PubMed ID: 39305652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving response inhibition systems in frontotemporal dementia with citalopram.
    Hughes LE; Rittman T; Regenthal R; Robbins TW; Rowe JB
    Brain; 2015 Jul; 138(Pt 7):1961-75. PubMed ID: 26001387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopy in frontotemporal lobar degeneration-related syndromes.
    Murley AG; Tsvetanov KA; Rouse MA; Jones PS; Sværke K; Li W; Carpenter A; Rowe JB
    Neurobiol Aging; 2022 Mar; 111():64-70. PubMed ID: 34971846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes.
    Murley AG; Coyle-Gilchrist I; Rouse MA; Jones PS; Li W; Wiggins J; Lansdall C; Rodríguez PV; Wilcox A; Tsvetanov KA; Patterson K; Lambon Ralph MA; Rowe JB
    Brain; 2020 May; 143(5):1555-1571. PubMed ID: 32438414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic changes associated with frontotemporal lobar degeneration syndromes.
    Murley AG; Jones PS; Coyle Gilchrist I; Bowns L; Wiggins J; Tsvetanov KA; Rowe JB
    J Neurol; 2020 Aug; 267(8):2228-2238. PubMed ID: 32277260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA-ergic Dynamics in Human Frontotemporal Networks Confirmed by Pharmaco-Magnetoencephalography.
    Adams NE; Hughes LE; Phillips HN; Shaw AD; Murley AG; Nesbitt D; Cope TE; Bevan-Jones WR; Passamonti L; Rowe JB
    J Neurosci; 2020 Feb; 40(8):1640-1649. PubMed ID: 31915255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reorganization of cortical oscillatory dynamics underlying disinhibition in frontotemporal dementia.
    Hughes LE; Rittman T; Robbins TW; Rowe JB
    Brain; 2018 Aug; 141(8):2486-2499. PubMed ID: 29992242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype.
    Sami S; Williams N; Hughes LE; Cope TE; Rittman T; Coyle-Gilchrist ITS; Henson RN; Rowe JB
    Brain; 2018 Aug; 141(8):2500-2510. PubMed ID: 30060017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial.
    Boxer AL; Knopman DS; Kaufer DI; Grossman M; Onyike C; Graf-Radford N; Mendez M; Kerwin D; Lerner A; Wu CK; Koestler M; Shapira J; Sullivan K; Klepac K; Lipowski K; Ullah J; Fields S; Kramer JH; Merrilees J; Neuhaus J; Mesulam MM; Miller BL
    Lancet Neurol; 2013 Feb; 12(2):149-56. PubMed ID: 23290598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
    Seltman RE; Matthews BR
    CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humour processing in frontotemporal lobar degeneration: A behavioural and neuroanatomical analysis.
    Clark CN; Nicholas JM; Henley SM; Downey LE; Woollacott IO; Golden HL; Fletcher PD; Mummery CJ; Schott JM; Rohrer JD; Crutch SJ; Warren JD
    Cortex; 2015 Aug; 69():47-59. PubMed ID: 25973788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotransmitter deficits from frontotemporal lobar degeneration.
    Murley AG; Rowe JB
    Brain; 2018 May; 141(5):1263-1285. PubMed ID: 29373632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of NMDA receptor antagonist memantine on mismatch negativity.
    Korostenskaja M; Nikulin VV; Kicić D; Nikulina AV; Kähkönen S
    Brain Res Bull; 2007 May; 72(4-6):275-83. PubMed ID: 17452287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy.
    Illán-Gala I; Montal V; Borrego-Écija S; Vilaplana E; Pegueroles J; Alcolea D; Sánchez-Saudinós B; Clarimón J; Turón-Sans J; Bargalló N; González-Ortiz S; Rosen HJ; Gorno-Tempini ML; Miller BL; Lladó A; Rojas-García R; Blesa R; Sánchez-Valle R; Lleó A; Fortea J;
    Brain; 2019 Apr; 142(4):1121-1133. PubMed ID: 30906945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.
    Rohrer JD; Lashley T; Schott JM; Warren JE; Mead S; Isaacs AM; Beck J; Hardy J; de Silva R; Warrington E; Troakes C; Al-Sarraj S; King A; Borroni B; Clarkson MJ; Ourselin S; Holton JL; Fox NC; Revesz T; Rossor MN; Warren JD
    Brain; 2011 Sep; 134(Pt 9):2565-81. PubMed ID: 21908872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal Dementia.
    Toller G; Cobigo Y; Ljubenkov PA; Appleby BS; Dickerson BC; Domoto-Reilly K; Fong JC; Forsberg LK; Gavrilova RH; Ghoshal N; Heuer HW; Knopman DS; Kornak J; Lapid MI; Litvan I; Lucente DE; Mackenzie IR; McGinnis SM; Miller BL; Pedraza O; Rojas JC; Staffaroni AM; Wong B; Wszolek ZK; Boeve BF; Boxer AL; Rosen HJ; Rankin KP;
    Neurology; 2022 Aug; 99(5):e488-e499. PubMed ID: 35584922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.